A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor
一项评估佩西达替尼治疗东亚腱鞘巨细胞瘤患者疗效和安全性的3期研究
期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-025-00365-z
Xu, Hairong; Wu, Po-Kuei; Ye, Zhaoming; Fan, Zhengfu; Li, Tao; Chen, Tom Wei-Wu; Shen, Jingnan; Yan, Wangjun; Achiwa, Issei; Yoh, Kazukoh; Kikumori, Kunika; Hiruma, Yoshiharu; Greenberg, Jonathan; Niu, Xiaohui